Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 124

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 124
---
 yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company financial statements.

New accounting standards not yet adopted

In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The purpose of the update was to improve financial reporting by requiring disclosures of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. The amendments in this ASU are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted and requires retrospective application to all periods presented in the consolidated financial statements. Management is evaluating the impact on the Company’s consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures.

<div align='center'>66

INDUSTRY</div>

The information that appears in this Industry Overview contains information and statistics on the industry in which we operate. Certain information and statistics set forth in this section have been extracted from a market research report by Frost & Sullivan, an Independent Third Party which we commissioned (the “FS Report”).

Traditional and Complementary Medicine (T&CM) Market in Hong Kong

Overview

Traditional and Complementary Medicine (T&CM) refers to a broad spectrum of medical practices and products that fall outside conventional Western medicine. In Hong Kong, the T&CM market primarily consists of the following categories:

| ● | Natural                                                                                     
 Products: This includes herbal remedies, vitamins, minerals, and other dietary supplements. 
 These products are often derived from natural sources and are used to support health and    
 prevent illness.                                                                            |

| ● | Mind                                                                                        
 and Body Practices: Such practices include acupuncture, yoga, meditation, chiropractic      
 care, and massage therapy. These interventions focus